SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Pain control, breast initiatives at cancer conference

Wednesday October 7th, 2009

Cancer patients can benefit significantly from extra information on coping with pain and managing their medicine, a UK cancer conference is to be told today.

The findings are among a welter of research projects to be reported to the conference of the National Cancer Research Institute in Birmingham, UK.

This new research suggests that the extra knowledge can result in a 20 per cent improvement in pain control.

Lead researcher, Professor Michael Bennett of Lancaster University, UK, said: "This is good news for cancer patients."

His team are calling for educational programmes on managing cancer pain and strong pain-killers to be given routinely alongside treatment drugs for cancer.

The conference also heard:

* Black and Asian women in Britain are significantly more likely than white women to be diagnosed with breast cancer that has spread, so targeted symptom awareness campaigns are urgently needed.

* Scientists from Manchester University, UK, are testing a pioneering radiotherapy treatment called radioimmunotherapy, which works by tagging an antibody to a molecule to deliver radiotherapy straight to the tumour. This improves accuracy, avoids damaging healthy cells, and reduces side-effects.

* A new class of cancer drugs, called PARP inhibitors, is being tested in mice for their action against breast and ovarian cancer. Cancer cells with low oxygen levels are particularly sensitive to the drugs.

* Almost forty per cent of British people would postpone a GP visit "because they don't want to bother the doctor", according to a recent survey. Professor Jane Wardle of Cancer Research UK said this can be dangerous. "A lot of work now needs to be done to help people feel like they can go to their doctor as soon as they find something that could be a symptom of cancer."

* Some 4,000 British women are to take part in research to see if hormone replacement therapy can help with breast cancer treatment. HRT will be given for just two weeks to see if it can help doctors decide how to tailor treatments as part of the POETIC project.

The National Cancer Research Institute conference is taking place in Birmingham, UK, from October 4 to 7.

Tags: Cancer | Pain Relief | UK News | Women’s Health & Gynaecology

Printer friendly page Printer friendly page

CATEGORIES